ResearchMoz

Browse All Vaccine Market Research Reports

List of reports from Vaccine

Displaying 1 to 30 (of 198 records)
China Human Vaccine Industry Report, 2014-2017
Sep 2014   |   By - Research In China
Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlier, and the market size expanded 2.8% year on year. As vaccination is suspected of causing death and some companies (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) have to...
$2600
Vaccines-Pipeline Insights, 2014
Aug 2014   |   By - DelveInsight
The Report will be Dispatched in 3 Working Days.  DelveInsights, Vaccines-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Vaccines. This report provides information on the therapeutic development...
$1250
Global and Chinese Veterinary Vaccine Industry, 2009-2019 Market Research Report
Aug 2014   |   By - Prof Research
Market Research Report on Global and Chinese Veterinary Vaccine Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Veterinary Vaccine industry. The report firstly reviews the basic information of Veterinary Vaccine including its classification, application and manufacturing technology; The report then explores global and Chinas top manufacturers of Veterinary...
$2400
Immunovaccine, Inc. - Product Pipeline Review - 2014
Jul 2014   |   By - Global Markets Direct
Immunovaccine, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, Immunovaccine, Inc. - Product Pipeline Review - 2014, provides an overview of the Immunovaccine, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Immunovaccine, Inc.s, complete with comparative analysis at...
$1500
VBI Vaccines - Product Pipeline Review - 2014
Jul 2014   |   By - Global Markets Direct
VBI Vaccines - Product Pipeline Review - 2014 Summary Global Markets Directs, VBI Vaccines - Product Pipeline Review - 2014, provides an overview of the VBI Vacciness pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of VBI Vacciness, complete with comparative analysis at various stages,...
$1500
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
Jul 2014   |   By - GlobalData
Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including...
$7995
Vaccine Partnering Terms and Agreements
Jul 2014   |   By - Current Partnering
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by...
$2995
China Animal Vaccine Industry Report, 2013-2016
Jun 2014   |   By - Research In China
Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main force of traditional animal vaccine markets in the world, still taking around 60% nowadays. In recent years, European and American animal vaccine markets have decelerated growth due to quality...
$2500
Global Encephalitis Vaccine Industry 2014 Market Research Report
Jun 2014   |   By - 9Dimen Research
was a professional and depth research report on Global Encephalitis Vaccine industry that you would know the world's major regional market conditions of Encephalitis Vaccine industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Encephalitis Vaccine basic information...
$2850
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
Jun 2014   |   By - GBI Research
GBI Research, a leading business intelligence provider, has released its latest research report: “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany”. Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the...
$3500
Vaccinex, Inc. - Product Pipeline Review - 2014
May 2014   |   By - Global Markets Direct
Vaccinex, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, Vaccinex, Inc. - Product Pipeline Review - 2014, provides an overview of the Vaccinex, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vaccinex, Inc.s, complete with comparative analysis at various stages,...
$1500
Wellstat Vaccines, LLC - Product Pipeline Review - 2014
May 2014   |   By - Global Markets Direct
Wellstat Vaccines, LLC - Product Pipeline Review - 2014 Summary Global Markets Directs, Wellstat Vaccines, LLC - Product Pipeline Review - 2014, provides an overview of the Wellstat Vaccines, LLCs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Wellstat Vaccines, LLCs, complete with comparative...
$1500
Vaccines Markets in China
May 2014   |   By - Asia Market Information & Development Company
China's demand for Vaccines has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and...
$4000
Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)
Apr 2014   |   By - Daedal Research
With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing at a steady pace, mainly because of the various existing and emerging diseases which...
$800
Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Apr 2014   |   By - Transparency Market Research
The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate and combination vaccines. The vaccine types are further segmented into different brands. The report also highlights and analyzes various brands under pipeline segment, namely, Bexsero, MnB rLP2806 and NmVac-4DT. A detailed market analysis and forecast for these segments has been...
$4795
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$10995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$4995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
t the traditional target population of adolescent girls remain persistently low. Initially HPV vaccines were developed and marketed solely to protect against cervical cancer. In recent years the role of HPV in other cancers has been increasingly recognized which has facilitated a shift towards vaccinating a wider population, most significant has been the inclusion of males in routine vaccine...
$6995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$4995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently...
$4995
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low....
$4995
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV...
$3495
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV...
$3495
V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022
Mar 2014   |   By - GlobalData
V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initially HPV...
$3495
PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players
Mar 2014   |   By - GlobalData
PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players Summary GlobalData has released its pharma report, PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prophylactic Human Papillomavirus Vaccines Market. The...
$2995
Competitor Analysis: Cancer Vaccines
Mar 2014   |   By - La Merie Publishing
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail...
$1112
Global and Chinese Vaccine linkage production line Industry, 2009-2019 Market Research Report
Mar 2014   |   By - Prof Research
Market Research Report on Global and Chinese Vaccine linkage production line Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Vaccine linkage production line industry. The report firstly reviews the basic information of Vaccine linkage production line including its classification, application and manufacturing technology; The report then explores global and...
$2400
Global and China Recombinant Hepatitis B Vaccine (Hansenula polymorpha) Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Recombinant Hepatitis B Vaccine(Hansenula polymorpha) basic information included Recombinant Hepatitis B Vaccine(Hansenula polymorpha) definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence,...
$2200
Global and China Influenza Vaccine (Split Virion),Inactivated Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Influenza Vaccine (Split Virion),Inactivated basic information included Influenza Vaccine (Split Virion),Inactivated definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Influenza Vaccine (Split...
$2200
Vaccine Development Strategies - Refocusing Efforts to Address New Challenges
Feb 2014   |   By - CBR Pharma Insights
Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and bacterial diseases now effectively generated, vaccine R&D is turning to areas of unmet need. Preventative vaccination in adults and against pathogens that affect the developing world is...
$3900
 
Displaying 1 to 30 (of 198 records)

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData

Popular Categories

 

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Upcoming Reports